Evidence map›Paper›PMID 40982533›Full record

ArticleThe Journal of infectious diseases2026

Mesenteric Ischemia and Bacterial Translocation Precipitate the Intoxication Phase of Yellow Fever.

Mateus V Thomazella, Xueer Qiu, Cássia Gisele Terrassani Silveira, Carolina A Correia, Mariana P Marmorato, Erik Sanson, Andrew Norton, Mark Sharobim, Yeh-Li Ho, Marisa Dolhnikoff and 4 more

Abstract read
In one paragraph

Article in The Journal of infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Mateus V ThomazellaMedical Investigation Laboratory 60, School of Medicine, University of São Paulo, São Paulo, Brazil.
Xueer QiuDepartment of Pathology and Laboratory Medicine, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Cássia Gisele Terrassani SilveiraMedical Investigation Laboratory 60, School of Medicine, University of São Paulo, São Paulo, Brazil.
Carolina A CorreiaMedical Investigation Laboratory 60, School of Medicine, University of São Paulo, São Paulo, Brazil.
Mariana P MarmoratoMedical Investigation Laboratory 60, School of Medicine, University of São Paulo, São Paulo, Brazil.
Erik SansonDepartment of Pathology and Laboratory Medicine, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Andrew NortonDepartment of Pathology and Laboratory Medicine, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Mark SharobimDepartment of Pathology and Laboratory Medicine, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Yeh-Li HoDepartment of Infectious Diseases and Tropical Medicine, School of Medicine, University of São Paulo, São Paulo, Brazil.
Marisa DolhnikoffDepartment of Pathology, Faculty of Medicine, University of São Paulo, São Paulo, Brazil.
Eduard MatkovicDepartment of Pathology and Laboratory Medicine, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Esper G KallasMedical Investigation Laboratory 60, School of Medicine, University of São Paulo, São Paulo, Brazil.
Amaro Nunes Duarte-NetoDepartment of Pathology, Faculty of Medicine, University of São Paulo, São Paulo, Brazil.
Adam L BaileyDepartment of Pathology and Laboratory Medicine, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, USA.

Funding

Integrated Training For Physician-ScientistsT32GM140935 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI Anna Huttenlocher, Jeniel E Nett · 2021 to 2026
$6.5M
Determinants of yellow fever pathogenesis in humansDP5OD029608 · OD · UNIVERSITY OF WISCONSIN-MADISON · PI BAILEY, ADAM LEE · 2020 to 2024
$1.9M
Conselho Nacional de Desenvolvimento Científico e TecnológicoDepartment of Pathology and Laboratory Medicine and the School of Medicine and Public Health at the University of Wisconsin-MadisonNIGMS NIH HHS T32 GM140935NIH HHS DP5 OD029608São Paulo Research Foundation
6 · The paper itself

Abstract

backgroundYellow fever (YF) is classically conceptualized as a hepatotropic disease; indeed, the liver is the primary site of yellow fever virus (YFV) replication. However, circumstantial evidence suggests that extrahepatic disease may be important for the approximately 30% of YF cases that progress to the severe "intoxication" phase of the disease.

methodsUsing a Syrian hamster-adapted (HA) YFV, we worked backwards from observations in humans to examine early events that precipitate the intoxication phase of YF.

resultsHA-YFV caused severe disease in approximately 80% of infected animals characterized by lethargy and weight loss that progressed to widespread petechiae and death by day 6. Clinical chemistry, coagulation testing, histology, immunohistochemistry, and in situ hybridization were consistent with a cascade of hepatocyte-specific virus replication causing liver damage and a defect in clotting factor synthesis. Despite a lack of extrahepatic HA-YFV replication, severe pathology was observed in the intestines and pancreas. Histopathological analysis over the time-course of HA-YFV infection revealed an ischemic pattern in these tissues, culminating in fibrinoid/coagulative necrosis of these organs. Further investigation showed that ischemia-induced erosion of the gut epithelial barrier serves as an entry point for luminal bacteria that spread systemically via the portal system. Thus, the intoxication phase of YF appears to be a sepsis-like syndrome caused by translocation of bacteria from a damaged gastrointestinal tract. Evaluation of human YF cases for these previously disconnected disease features confirmed this overarching mechanism: Bacteria were identified in the portal vein and liver parenchyma of fatal YF cases along with elevations in plasma markers of bacteremia and a bacteria-driven inflammatory response. Importantly, blood concentrations of the gastrointestinal damage marker intestinal fatty acid binding protein (I-FABP) were significantly elevated in fatal YF cases relative to nonfatal cases, suggesting that I-FABP measurements could be useful in prognosis and treatment decision-making.

conclusionsOur findings tie together several recent and historically unexplained observations surrounding the highly lethal intoxication phase of YF in humans: a high aspartate aminotransferase/alanine aminotransferase ratio, "black vomit," pancreatitis, and paradoxical neutrophilia. A better appreciation for the drivers of mesenteric ischemia, and preemption of bacterial sepsis, may improve outcomes in cases of severe YF.

Indexed as

Bacterial TranslocationMesenteric IschemiaYellow FeverYellow fever virusAnimalsCricetinaeDisease Models, AnimalHumansLiverMaleMesocricetusVirus Replicationflavivirusintoxication phaseorthoflavivirusviral hemorrhagic feveryellow fever

Identifiers

PMID40982533
PMCPMC12747459

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.